StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Price Performance
RKDA opened at $6.36 on Thursday. The company has a market capitalization of $8.68 million, a price-to-earnings ratio of -1.49 and a beta of 0.90. The business’s 50-day moving average price is $4.61 and its two-hundred day moving average price is $3.54. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31.
Arcadia Biosciences Company Profile
Featured Articles
- Five stocks we like better than Arcadia Biosciences
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- What is a Bond Market Holiday? How to Invest and Trade
- Nebius Group: The Rising Star in AI Infrastructure
- What Do S&P 500 Stocks Tell Investors About the Market?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.